ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $90,802,000 | +103084.1% | 62,193 | 0.0% | 0.00% | – |
Q4 2016 | $88,000 | -58.1% | 62,193 | -48.2% | 0.00% | – |
Q3 2016 | $210,000 | +2.4% | 120,093 | 0.0% | 0.00% | – |
Q2 2016 | $205,000 | -13.1% | 120,093 | 0.0% | 0.00% | – |
Q1 2016 | $236,000 | +0.4% | 120,093 | -3.0% | 0.00% | – |
Q4 2015 | $235,000 | -0.4% | 123,811 | 0.0% | 0.00% | – |
Q3 2015 | $236,000 | -51.3% | 123,811 | +18.6% | 0.00% | – |
Q2 2015 | $485,000 | +13.8% | 104,411 | +7.2% | 0.00% | – |
Q1 2015 | $426,000 | +31.9% | 97,411 | +5.0% | 0.00% | – |
Q4 2014 | $323,000 | -8.5% | 92,811 | +10.3% | 0.00% | – |
Q3 2014 | $353,000 | -28.4% | 84,111 | 0.0% | 0.00% | – |
Q2 2014 | $493,000 | -7.0% | 84,111 | 0.0% | 0.00% | -100.0% |
Q1 2014 | $530,000 | +7.7% | 84,111 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $492,000 | +14.2% | 84,111 | +2.8% | 0.00% | 0.0% |
Q3 2013 | $431,000 | -31.5% | 81,811 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $629,000 | – | 81,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |